Windtree Therapeutics, Inc. (WINT) Revenue History
Annual and quarterly revenue from 1995 to present
WINT Revenue Over Time (1995–2024)
WINT Revenue Growth History
11 of 21 years with positive growth- FY1995 revenue growth
- N/A
- FY1996 revenue growth
- +100.0%
- FY1997 revenue growth
- +250.0%
- FY1998 revenue growth
- -85.7%
- FY1999 revenue growth
- +78.0%
- FY2000 revenue growth
- +316.3%
- FY2001 revenue growth
- +50.1%
- FY2002 revenue growth
- +60.3%
- FY2003 revenue growth
- -41.8%
- FY2004 revenue growth
- +16.6%
- FY2005 revenue growth
- -88.9%
- FY2006 revenue growth
- -100.0%
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- N/A
- FY2009 revenue growth
- -100.0%
- FY2010 revenue growth
- N/A
- FY2011 revenue growth
- N/A
- FY2012 revenue growth
- -66.5%
- FY2013 revenue growth
- +99.0%
- FY2014 revenue growth
- +630.7%
- FY2015 revenue growth
- -65.2%
- FY2016 revenue growth
- +106.9%
- FY2017 revenue growth
- -27.3%
- FY2018 revenue growth
- +20.4%
- FY2019 revenue growth
- -88.9%
- FY2020 revenue growth
- -100.0%
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $90K | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
| Q1 2024 | $0 | — |
| Q4 2023 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
WINT Revenue Analysis (1995–2024)
Current Revenue & Growth
As of June 21, 2026, Windtree Therapeutics, Inc. (WINT) generated trailing twelve-month (TTM) revenue of $90,000. The most recent quarter (Q3 2025) recorded $0 in revenue
Historical Growth Trajectory
WINT's historical revenue data shows various trends over time. Windtree Therapeutics, Inc.'s highest annual revenue of $4.6 million was recorded in 2008.
Peer Comparison
Compared to Healthcare sector peers — including NKTR (-36.2% YoY), AGIO (+78.3% YoY), and PRTA (-58.0% YoY). Compare WINT vs NKTR →
WINT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| WINTCurrent | $90,000 | - | - | - | |
 NKTR | $55M | -36.2% | -18.4% | -236.8% | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
WINT Historical Revenue Data (1995–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-84,000 | - | $-25,019,000 | - |
| 2023 | $0 | - | $-82,000 | - | $-17,539,000 | - |
| 2022 | $0 | - | $-1,061,000 | - | $-41,333,000 | - |
| 2021 | $0 | - | $-869,000 | - | $-77,280,000 | - |
| 2020 | $0 | -100.0% | $-638,000 | - | $-30,317,000 | - |
| 2019 | $198K | -88.9% | $185K | 93.6% | $-24,893,000 | -12572.2% |
| 2018 | $1.8M | +20.4% | $-8,774,000 | -490.7% | $-16,195,000 | -905.8% |
| 2017 | $1.5M | -27.3% | $-15,891,000 | -1070.1% | $-22,548,000 | -1518.4% |
| 2016 | $2.0M | +106.9% | $1.8M | 87.5% | $-38,036,000 | -1862.7% |
| 2015 | $987K | -65.2% | $58K | 5.9% | $-39,834,000 | -4035.9% |
| 2014 | $2.8M | +630.7% | $164K | 5.8% | $-43,258,000 | -1525.9% |
| 2013 | $388K | +99.0% | $-129,000 | -33.2% | $-44,508,000 | -11471.1% |
| 2012 | $195K | -66.5% | $173K | 88.9% | $-37,819,000 | -19394.4% |
| 2011 | $582K | - | $582K | 100.0% | $-24,512,000 | -4211.7% |
| 2010 | $0 | - | $0 | - | $-25,528,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
WINT — Frequently Asked Questions
Quick answers to the most common questions about buying WINT stock.
Is WINT's revenue growth accelerating or slowing?
WINT TTM revenue: $90000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is WINT's revenue history from 1995 to 2026?
Windtree Therapeutics, Inc. (WINT) revenue history spans 1995 to 2026. TTM revenue as of 2026 is $90000.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is WINT's long-term revenue growth rate (CAGR)?
Windtree Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for WINT.
Why does WINT's quarterly revenue fluctuate?
WINT quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Windtree Therapeutics, Inc.'s revenue data from 1995 to 2026 shows full historical quarterly detail on this page.
How is WINT's revenue distributed by segment?
WINT reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does WINT's revenue compare to industry peers?
Windtree Therapeutics, Inc. (WINT) with TTM revenue of $90000.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.